This milestone of TargetCancer Foundation’s 15 year anniversary has stopped me in my tracks. It is a long time to be doing this work and a long time to grieve...
News
2023: An Impactful Year In Review
RESEARCH → TCF-001 TRACK Our fully remote, decentralized precision medicine clinical trial has enrolled 157 patients with 40 rare cancers from 41 states,...
Thank you to our Community Fundraisers!
February is Cholangiocarcinoma Awareness Month. We are proud to highlight the many efforts from TCF community members who are working to bring attention to...
TCF Executive Director Jim Palma to Receive the 2022 Ruesch Center Luminary Award in GI Cancers
We are incredibly proud to announce that our Executive Director Jim Palma has been named a Ruesch Center 2022 Luminary Awards in GI Cancer recipient!...
A reflection of purpose after 13 years: Remembering our founder
Written by Kristen Palma, TargetCancer Foundation President Each year, as I sit down to write this note, I wonder what more I can say. It has been 13...
Introducing Giselle Mota, our newest volunteer!
We are pleased to introduce you to TargetCancer Foundation's newest volunteer, Giselle Mota. Originally from Los Angeles, CA, Giselle currently resides in...
Promising New Cholangiocarcinoma Treatment Findings
An exciting paper was recently published in Cancer Discovery highlighting the promise of the recently FDA approved FGFR inhibitor drugs for an even broader...
In Julienne’s Footsteps: Climbing Mt. Kilimanjaro to Honor a Life
By guest writer Karen Dempsey The bonds that Julienne Morriss Callaway forged and the values she embraced in life have been instrumental in sustaining her...
An Insider’s Perspective
Dr. Monika Laszkowska, a gastroenterology fellow, next to the poster she presented at the 2019 TargetCancer Foundation Think Tank on Advancing...
2019 Cholangiocarcinoma Research Grant Announcement
TargetCancer Foundation is proud to announce a new two-year, $240,000 grant to the Bardeesy Lab at the Massachusetts General Hospital Cancer Center brings our...
Building the tools of cholangiocarcinoma research- a researcher’s reflection.
In December 2019, TargetCancer Foundation announced $240,000 in new cholangiocarcinoma grant funding. The following post was written by Grant Recipient Nabeel...
10 years ago today.
Today TargetCancer Foundation remembers our founder, Paul Poth, whose life was taken by cholangiocarcinoma at age 39 on this day ten years ago- August 22,...
Team TargetCancer Foundation 2017 Runner Profile: Daniel Rothenberg
By TargetCancer Foundation Advocacy Council Member Kim Balkus Every marathon runner has a unique story. But very few runners not only know how to complete a...
Looking back at 2016
As 2016 draws to a close, we are proud to look back on an outstanding year of new programs and research success for TargetCancer Foundation. In 2016...
TargetCancer Foundation Gala Spotlight: Leslie Condon
Leading up to the 7th Annual TargetCancer Foundation Gala, we will be sharing stories and perspectives on the gala from the many people who make up the...